Ozempic may help treat kidney disease in diabetic patients
Summary: Semaglutide, found in Ozempic and Wegovy, significantly reduced kidney complications, heart issues, and death in Type 2 diabetes patients with chronic kidney disease. The trial's success led Novo Nordisk to halt it early. The company plans to seek FDA approval to update Ozempic's label for treating chronic kidney disease in diabetic patients. Chronic kidney disease affects over one in seven US adults and has no cure.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings